Dotinurad
多替诺雷
Report date: 2026/05/23 20:00:57
NME
Base Information
Drug NameDotinurad
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2020/01/23
Country/Territory +[5]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFuji Yakuhin Co Ltd
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksKEGG